Identification of ligand-selective peptidic ActRIIB-antagonists using phage display technology

[1]  Takashi Ito,et al.  Generation of a novel artificial TrkB agonist, BM17d99, using T7 phage-displayed random peptide libraries. , 2017, Biochemical and biophysical research communications.

[2]  A. Kadotani,et al.  Novel DOCK2-selective inhibitory peptide that suppresses B-cell line migration. , 2017, Biochemical and biophysical research communications.

[3]  Kotaro Sakamoto,et al.  Discovery of high-affinity BCL6-binding peptide and its structure-activity relationship. , 2017, Biochemical and biophysical research communications.

[4]  A. Kadotani,et al.  Discovery of GPX4 inhibitory peptides from random peptide T7 phage display and subsequent structural analysis. , 2017, Biochemical and biophysical research communications.

[5]  Takashi Ito,et al.  Discovery of an artificial peptide agonist to the fibroblast growth factor receptor 1c/βKlotho complex from random peptide T7 phage display. , 2016, Biochemical and biophysical research communications.

[6]  M. Franti,et al.  Crystal structure of human GDF11. , 2016, Acta crystallographica. Section F, Structural biology communications.

[7]  Ernest Giralt,et al.  Modulating protein-protein interactions: the potential of peptides. , 2015, Chemical Communications.

[8]  A. Grinberg,et al.  Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis , 2014, Nature Medicine.

[9]  T. Hornberger,et al.  Faculty Opinions recommendation of Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. , 2014 .

[10]  S. Brachat,et al.  An Antibody Blocking Activin Type II Receptors Induces Strong Skeletal Muscle Hypertrophy and Protects from Atrophy , 2013, Molecular and Cellular Biology.

[11]  B. Lin,et al.  Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders , 2013, Current opinion in supportive and palliative care.

[12]  L. Wakefield,et al.  Beyond TGFβ: roles of other TGFβ superfamily members in cancer , 2013, Nature Reviews Cancer.

[13]  A. Grinberg,et al.  Specificity and Structure of a High Affinity Activin Receptor-like Kinase 1 (ALK1) Signaling Complex , 2012, The Journal of Biological Chemistry.

[14]  Chandramohan Kattamuri,et al.  Structure of Myostatin·Follistatin-like 3 , 2011, The Journal of Biological Chemistry.

[15]  J. Lachey,et al.  Soluble activin receptor type IIB increases forward pulling tension in the mdx mouse , 2011, Muscle & nerve.

[16]  T. B. Thompson,et al.  The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding , 2009, The EMBO journal.

[17]  S. Hatakeyama,et al.  Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. , 2009, American journal of physiology. Cell physiology.

[18]  A. Pestronk,et al.  A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy , 2008, Annals of neurology.

[19]  Mallika Singh,et al.  Crystal Structure of BMP-9 and Functional Interactions with Pro-region and Receptors* , 2005, Journal of Biological Chemistry.

[20]  S. Choe,et al.  A flexible activin explains the membrane-dependent cooperative assembly of TGF-beta family receptors. , 2004, Molecular cell.

[21]  T. Jardetzky,et al.  Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF‐β ligand:receptor interactions , 2003, The EMBO journal.

[22]  P. ten Dijke,et al.  Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter* , 2002, The Journal of Biological Chemistry.